Chemoprotective and adjuvant effects of immunomodulator ginsan in cyclophosphamide-treated normal and tumor bearing mice

International Journal of Immunopathology and Pharmacology

Volumn 20, Issue 3, 2007, Pages 487-497

  Shim, J Y ^a   Han, Y ^a   Ahn, J Y ^a   Yun, Y S ^a   Song, Jie Young ^a  

^a Korea Institute of Radiation and Medical Science   (South Korea)

Author keywords

Chemoprotection; Cyclophosphamide; Ginsan; Immunomodulator

Indexed keywords

CYCLOPHOSPHAMIDE; GINSAN; GINSENG EXTRACT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEMATOPOIETIC STEM CELL; IMMUNOMODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

EID: 34948850764     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200702000307     Document Type: Article

References (38)

1. Mesner P.W., I.I. Budihardjo and S.H. Kaufmann. 1997. Chemotherapy-induced apoptosis. Adv. Pharmacol. 41:461.
2. Proietti E., G. Greco, B. Garrone, S. Baccarani, C. Mauri, M. Venditti, D. Carlei and F. Belardelli. 1998. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice. J. Clin. Invest. 101:429.
3. Binotto G., L. Trentin and G. Semenzato. 2003. Ifosfamide and cyclophosphamide. Effects on immunosurveillance. Oncology 65:17.
4. Colvin O.M. 1999. An overview of cyclophosphamide development and clinical applications. Current Pharmaceutical Design. 5:555.
5. Sefc L., O. Psenak, V. Sykora, K. Sulc and E. Necas. 2003. Response of hematopoiesis to cyclophosphamide follows highly specific patterns in bone marrow and spleen. J. Hematother. and Stem Cell Res. 12:47.
6. Boddy A.V. and S.M. Yule. 2000. Mechanism and pharmacokinetics of oxazaphosphorines. Clin. Pharmacokinet. 38:291.
7. Kuttan G. and R. Kuttan. 1992. Immunological mechanism of action of the tumor reducing peptide from mistletoe extract (NSC 635089) cellular proliferation. Cancer Lett. 66:123.
8. Kuttan G. and R. Kuttan. 1992. Immunomodulatory activity of a peptide isolated from Viscum album extract (NSC 635 089). Immunol. Invest. 21:285.
9. Kroes B.H., C.J. Beukelman, A.J. van den Berg, G.J. Wolbink, H. van Dijk and R.P. Labadie. 1997. Inhibition of human complement by beta-glycyrrhetinic acid. Immunology 90:115.
10. Nose M., K. Terawaki, K. Oguri, Y. Ogihara, K. Yoshimatsu and K. Shimomura. 1998. Activation of macrophages by crude polysaccharide fractions obtained from shoots of Glycyrrhiza glabra and hairy roots of Glycyrrhiza uralensis in vitro. Biol. Pharm. Bull. 21:1110.
11. Puebla-Perez A.M., X. Lozoya and M.M. Villasenor-Garcia. 2003. Effect of Ginkgo biloba extract, EGb 761, on the cellular immune response in a hypothalamic-pituitary-adrenal axis activation model in the rat. Int. Immunopharmacol. 3:75.
12. Wilasrusmee C., J. Siddiqui, D. Bruch, S. Wilasrusmee, S. Kittur and D.S. Kittur. 2002. In vitro immunomodulatory effects of herbal products. Am. Surg. 68:860.
13. Kyo E., N. Uda, S. Kasuga and Y. Itakura. 2001. Immunomodulatory effects of aged garlic extract. J. Nutr. 131:1075.
14. Banerjce U. and J.A. Izquierdo. 1982. Antistress and antifatigue properties of panax ginseng; Comparison with piracetan. Acta Physiol. Lat. Am. 32:277.
15. Deng H.L., J.T. Zhang and Y.S. Huang. 1989. Study on anti-lipid peroxidative effect of ginsenoside Rb1 and Rg1. Acta Chinese Med. Acad. 2:157.
16. Kiefer D. and T. Pantuso. 2003. Panax ginseng. Am. Fam. Phys. 68:1539.
17. Rai D., G. Bhatia, T. Sen and G. Palit. 2003. Antistress effects of Ginkgo biloba and Panax ginseng: a comparative study. J. Pharmacol. Sci. 93:458.
18. Lee Y.S., I.S. Jung, I.R. Lee, K.H. Kim, W.S. Hong and Y.S. Yun. 1997. Activation of multiple effector pathways of immune system by the antineoplastic immunostimulator acidic polysaccharide ginsan isolated from Panax ginseng. Anticancer Res. 17:323.
19. Song J.Y., S.K. Han, E.H. Son, S.N. Pyo, Y.S. Yun and S.Y. Yi. 2002. Induction of secretory and tumoricidal activities in peritoneal macrophages by ginsan. Int. Immunopharmacol. 2:865.
20. Song J.Y., S.Y. Yi, I.S. Jung and Y.S. Yun. 2001. Effect of polysaccharide extracted from Panax ginseng on murine hematopoiesis. J. Ginseng Res. 25:63.
21. Song J.Y., S.K. Han, K.G. Bae, D.S. Lim, S.J. Son, I.S. Jung, S.Y. Yi and Y.S. Yun. 2003. Radioprotective effects of ginsan, an immunomodulator. Radiat. Res. 159:768.
22. Magli M.C., N.N. Iscove and N. Odartehenko. 1982. Transient nature of early heamatopoietic spleen colonies. Nature 295:527.
23. Kumazawa Y., M. Kaneko, K. Inagaki, N. Matsuzaki and K. Nomoto. 1990. Accelerated recovery from γ-irradiation-induced leukopenia in mice by the biscoclaurine alkaloid Cepharanthin® - comparison with recombinant human granulocyte colony-stimulating factor. Int. J. Immunopharmacol. 12:523.
24. Till J.E. and E.A. McCulloch. 1961. A direct measurement effects of the radiation sensitivity of normal mouse cells irradiated and proliferating in vivo. Radiat. Res. 14:213.
25. Davis L. and G. Kuttan. 1998. Supressive effect of cyclophosphamide-induced toxicity by Withania somnifera extract in mice. J. Ethnopharmacol. 62:209.
26. Nygaard U.C. and M. Lovik. 2002. Blood and spleen lymphocytes as targets for immunotoxic effects in the rat - a comparison. Toxicology 174:153.
27. Ogawa M. 1993. Differentiation and proliferation of hematopoietic stem cells. Blood 81:2844.
28. Socolovsky M., S.N. Constantinescu, S. Bergelson, A. Sirotkin and H.F. Lodish. 1998. Cytokines in hematopoiesis: specificity and redundancy in receptor function. Adv. Protein Chem. 52:141.
29. Whetton A.D. and E. Spooncer. 1998. Role of cytokines and extracellular matrix in the regulation of haemopoietic stem cells. Curr. Opin. Cell Biol. 10:721.
30. Shalit I., Y. Kletter, D. Halperin, D. Waldman, E. Vasserman, A. Nagler and I. Fabian. 2001. Immunomodulatory effects of moxifloxacin in comparison to ciprofloxacin and G-CSF in a murine model of cyclophosphamide- induced leukopenia. Eur. J. Haematol. 66:287.
31. Metcalf D. 1985. The granulocyte-crophage colony-stimulating factors. Science 229:16.
32. Vadas M.A., N.A. Nicola and D. Metcalf. 1983. Activation of antibody-dependent cell-mediated cytotoxicity of the human neutrophils and eosinophils by separate colony-stimulating factors. J. Immunol. 130:795.
33. Dalton D.K., S. Pitts-Meek, S. Keshav, I.S. Figari, A. Bradley and T.A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-γ gene. Science 259:1739.
34. Weibart R.H., A. Kacena, A. Schuh and D.W. Golde. 1988. GM-CSF induces human neutrophil IgA-mediated phagocytosis by an IgA Fc receptor activation mechanism. Nature 332:647.
35. Kaufman S.E., J.F. Di Persio and J.C. Gasson. 1989. Effects of human GM-CSF on neutrophil degranulation in vitro. Exp. Hematol. 17:800.
36. Dalmau S.R., C.S. Freitas and D.G. Tabak. 1993. Interleukin-1 and tumor necrosis factor-alpha as radio- and chemoprotectors of bone marrow. Bone Marrow Transplant. 12:551.
37. Miller C.L. and C.J. Eaves. 1997. Expansion in vitro of adult murine hematopoietic stem cells with transplantable lympho-myeloid reconstituting activity. Proc. Natl. Acad. Sci. USA 94:13648.
38. +-selected human peripheral blood progenitor cells. Blood 84:2898.